Statistics for Harrow Health (id:6502 HROW)

Valuation metrics

Market cap

1.56B

Enterprise value

1.61B

Trailing P/E (ttm)

-57.20

Forward P/E

42.60

PEG ratio

42.60

Price/Sales (ttm)

9.24

Price/Book (mrq)

26.77

Enterprise Value/Revenue

9.50

Enterprise Value/EBITDA

586.53

Overview

Shares outstanding

35.61M

Float

26.17M

Shares short

2.58M

% Held by insiders

0.14%

% Held by institutions

0.59%

Average volume (10 days)

902.79K

Average volume (90 days)

Price summary

52-Week low

8.72

52-Week high

59.23

52-Week change

78.14%

Beta

0.76

50-Day moving average

47.89

200-Day moving average

26.60

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

February 08th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-19.75%

Operating margin

2.68%

Operational effectiveness

Return on assets

-1.68%

Return on equity

-50.23%

Income statement

Revenue (ttm)

4.76

Revenue per share (ttm)

4.76

Quarterly revenue growth (yoy)

Gross profit (ttm)

90.55M

EBITDA

12.71M

Net income to common (ttm)

-33,406,000.00

Diluted EPS (ttm)

-0.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

72.60M

Total cash per share (mrq)

2.06

Total debt (mrq)

186.06M

Total Debt/Equity (mrq)

322.90

Current ratio (mrq)

154.80%

Book value per share (mrq)

1.64

Cash flow

Cash flow statement

4.27M

Levered free cash flow (LFCF)

-100,520,000.00